MIRUM PHARMACEUTICALS INC
MIRMNASDAQ🏆 #1181 by market capEarnings Nov 3US Equity
$87.18▲ $1.40 (+1.63%)
Latest quoteTrack MIRM
Get earnings, price moves & breaking news on Telegram
24h▲ 1.6%
7d▲ 5.1%
14d▲ 6.0%
30d▼ 0.5%
ytd▲ 10.4%
1y▲ 23.8%
🏦Market Cap
$5.66B
Small Cap
📈Revenue Growth (YoY)
44.0%
High Growth
📊Gross Margin
81.7%
High
💵FCF Margin
9.2%
Moderate
⚖️P/S Ratio
8.9x
Elevated
Otter Score
68
Fair
MIRUM PHARMACEUTICALS INC
MIRMAnalyst Ratings
Price
$87.18
Total
18
Raised
0
Lowered
0
Avg PT
$153.20
H / L
$200 / $130
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-10-21 | — | — |
Stifel | Reiterated | Buy | 2026-10-15 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2026-10-13 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-10-13 | $152.00 | +74.40% |
Citigroup | Reiterated | Buy | 2026-10-12 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-10-12 | — | — |
RBC Capital | Reiterated | Outperform | 2026-10-08 | $155.00 | +77.80% |
Baird | Reiterated | Outperform | 2026-09-29 | — | — |
Citizens | Reiterated | Market Outperform | 2026-08-27 | — | — |
JP Morgan | Reiterated | Overweight | 2026-07-02 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-02-26 | $118.00 | +35.40% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-08 | $130.00 | +49.10% |
JMP Securities | Reiterated | Market Outperform | 2025-08-07 | $95.00 | +9.00% |
Raymond James | Reiterated | Strong Buy | 2025-08-07 | $165.00 | +89.30% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-24 | — | — |
HC Wainwright& Co. | Reiterated | Buy | 2023-06-15 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-10 | — | — |
Guggenheim | Reiterated | Buy | 2020-09-09 | — | — |
Institution
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Stifel
Reiterated · Buy · 2026-10-15
—
—
Evercore ISI Group
Reiterated · Outperform · 2026-10-13
—
—
Morgan Stanley
Reiterated · Overweight · 2026-10-13
$152.00
+74.40%
Citigroup
Reiterated · Buy · 2026-10-12
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-10-12
—
—
RBC Capital
Reiterated · Outperform · 2026-10-08
$155.00
+77.80%
Baird
Reiterated · Outperform · 2026-09-29
—
—
Citizens
Reiterated · Market Outperform · 2026-08-27
—
—
JP Morgan
Reiterated · Overweight · 2026-07-02
—
—
Leerink Partners
Reiterated · Outperform · 2026-02-26
$118.00
+35.40%
Cantor Fitzgerald
Reiterated · Overweight · 2025-12-08
$130.00
+49.10%
JMP Securities
Reiterated · Market Outperform · 2025-08-07
$95.00
+9.00%
Raymond James
Reiterated · Strong Buy · 2025-08-07
$165.00
+89.30%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-02-24
—
—
HC Wainwright& Co.
Reiterated · Buy · 2023-06-15
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-10
—
—
Guggenheim
Reiterated · Buy · 2020-09-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space